The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image)An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose…
Covid-19 update: However, Dr. Reddy’s will continue a late-stage North American trial of Avigan in patients with mild to moderate Covid-19 symptoms. (Reuters image)Covid- 19 update: Indian pharmaceutical giant Dr.…
The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. (Representational image: Reuters)Pfizer Inc. and BioNTech SE said the Covid-19…